Depression in chronic obstructive pulmonary disease: A common concomitant disease

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 5, 2011, Pages 562-563

  Jones, Paul W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CENTER FOR EPIDEMIOLOGIC SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COGNITIVE THERAPY; DEPRESSION; EDITORIAL; HUMAN; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PULMONARY REHABILITATION; SMOKING; SOCIAL ISOLATION;

DEPRESSIVE DISORDER; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79952221289     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201011-1839ED     Document Type: Editorial

References (3)

1. Hanania N, Müllerova H, Locantore N, Vestbo J, Wouters E, Rennard S, Sharafkhaneh A. Determinants of depression in the ECLIPSE COPD cohort. Am J Respir Crit Care Med 2011:183:604-611.
2. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, Czajkowski SM, DeBusk R, Hosking J, Jaffe A, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-3116. (Pubitemid 37432886)
3. Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010;CD007503 10.1002/14651858.CD007503.pub2.